Andrew Piper-Vallillo to Clinical Trials as Topic
This is a "connection" page, showing publications Andrew Piper-Vallillo has written about Clinical Trials as Topic.
Connection Strength
0.037
-
Sentana-Lledo D, Viray H, Piper-Vallillo AJ, Widick P, Rangachari D, Wilson JL, Gangadharan SP, Aronovitz JA, Berman SM, VanderLaan PA, Costa DB. Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancer. Lung Cancer. 2022 10; 172:124-126.
Score: 0.037